NPI Details
Brinda Matamana, MSN, FNP-C, APRN is a nurse practitioner in Carrollton, TX with 8 years of experience. The provider is (1) A registered nurse provider with a graduate degree in nursing prepared for advanced practice involving independent and interdependent decision making and direct accountability for clinical judgment across the health care continuum or in a certified specialty. (2) A registered nurse who has completed additional training beyond basic nursing education and who provides primary health care services in accordance with state nurse practice laws or statutes. Tasks performed by nurse practitioners vary with practice requirements mandated by geographic, political, economic, and social factors. Nurse practitioner specialists include, but are not limited to, family nurse practitioners, gerontological nurse practitioners, pediatric nurse practitioners, obstetric-gynecologic nurse practitioners, and school nurse practitioners. Brinda Matamana, MSN, FNP-C, APRN NPI is 1891265930. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a female.
The provider's business location address is:
4125 FAIRWAY DR STE 190
CARROLLTON, TX
ZIP 75010-506
Phone: (469) 431-0486
Fax: (844) 886-1058
The NPI 1891265930 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
- Injection, iron sucrose, 1 mg (HCPCS:J1756)
- Injection, omalizumab, 5 mg (HCPCS:J2357)
- Injection, tildrakizumab, 1 mg (HCPCS:J3245)
- Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
- Injection, denosumab, 1 mg (HCPCS:J0897)
- Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
- Injection of drug or substance under skin or into muscle (HCPCS:96372)
- Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg (HCPCS:J1599)
- Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
- Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
- Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
- Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
- Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
- Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
- Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
- New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
- Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
- Injection of additional new drug or substance into vein (HCPCS:96375)
The enumeration date for this NPI number is 12/2/2018 and was last updated on 9/9/2020.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
1 | 363L00000X | Nurse Practitioner | | AP139045 | TEXAS | Yes |